Role of severity and inflammation on the decrease of monocyte HLA-DR (MHLA-DR) in critically ill patients

Key Points

• Monocyte HLA-DR significantly decreases with increased inflammation and severity in critically ill patients, highlighting a potential biomarker for immune dysfunction.
• Patients in critical conditions show a marked reduction in HLA-DR expression, particularly in relation to inflammatory responses and disease severity.
• Assessment using blood samples demonstrated that those with higher severity scores had lower HLA-DR levels, suggesting a link that could aid in managing critical illness.
• Findings underscore the need for continuous monitoring of HLA-DR as it may help in understanding immune status and prognosis in critically ill patients with varying degrees of inflammation.